LOXL4 is a selectively expressed candidate diagnostic antigen in head and neck cancer.
Weise JB, Rudolph P, Heiser A, Kruse ML, Hedderich J, Cordes C, Hoffmann M, Brant O, Ambrosch P, Csiszar K, Görögh T.
Weise JB, et al. Among authors: hoffmann m.
Eur J Cancer. 2008 Jun;44(9):1323-31. doi: 10.1016/j.ejca.2008.03.026. Epub 2008 May 20.
Eur J Cancer. 2008.
PMID: 18499440